Decreased levels of CD95 and caspase-8 mRNA in multiple sclerosis patients with gadolinium-enhancing lesions on MRI

被引:11
作者
Gomes, AC [1 ]
Morris, M
Stawiarz, L
Jönsson, G
Putheti, P
Bronge, L
Link, H
Hillert, J
机构
[1] Huddinge Univ Hosp R54, Karolinska Inst, Div Neurol, Neurotec Dept, SE-14186 Stockholm, Sweden
[2] Huddinge Univ Hosp, Karolinska Inst, Div Radiol, SE-14186 Stockholm, Sweden
[3] Dartmouth Coll Sch Med, Hanover, NH USA
[4] Stockholm Univ, Wenner Gren Inst, Dept Immunol, SE-10691 Stockholm, Sweden
[5] Karolinska Inst, Neurotec Dept, Neuroimmunol Unit, SE-14183 Stockholm, Sweden
关键词
multiple sclerosis; magnetic resonance imaging; apoptosis; CD95; caspase-8; gadolinium-enhancing lesions;
D O I
10.1016/j.neulet.2003.08.030
中图分类号
Q189 [神经科学];
学科分类号
071006 [神经生物学];
摘要
Magnetic resonance imaging (MRI) allows examining inflammation and central nervous system (CNS) tissue damage in patients suffering from multiple sclerosis (MS), a demyelinating disease of the CNS. Using real-time PCR, we quantified mRNA levels of apoptosis regulators CD95, CD95 ligand, caspase-8, -10 and cellular FLICE-inhibitory protein (cFLIP), and cytokines IL-10 and TNF-alpha in blood mononuclear cells of MS patients at the time of MRI examination. Patients with detectable gadolinium-enhancing lesions had lower expression of CD95 and caspase-8 (P < 0.05). Lesion load and brain atrophy did not correlate with expression levels of any of the target molecules studied. Disease duration correlated positively with both FLIP/caspase-8 and CD95/CD3 ratios (P < 0.05). These results support the notion that the CD95-dependent pathway plays a complex role in the regulation of survival of activated immune cells in MS. (C) 2003 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:101 / 104
页数:4
相关论文
共 21 条
[1]
Aggarwal S, 1998, J IMMUNOL, V160, P1627
[2]
ELI-spot of Th-1 cytokine secreting PBMC's in multiple sclerosis: correlation with MRI lesions [J].
Calabresi, PA ;
Fields, NS ;
Farnon, EC ;
Frank, JA ;
Bash, CN ;
Kawanashi, T ;
Maloni, H ;
Jacobson, S ;
McFarland, HF .
JOURNAL OF NEUROIMMUNOLOGY, 1998, 85 (02) :212-219
[3]
Clinical and MRI disease activity in multiple sclerosis are associated with reciprocal fluctuations in serum and cerebrospinal fluid levels of soluble HLA class I molecules [J].
Fainardi, E ;
Granieri, E ;
Tola, MR ;
Melchiorri, L ;
Vaghi, L ;
Rizzo, R ;
Castellazzi, M ;
Ceruti, S ;
Paolino, E ;
Baricordi, OR .
JOURNAL OF NEUROIMMUNOLOGY, 2002, 133 (1-2) :151-159
[4]
Peripheral levels of caspase-1 mRNA correlate with disease activity in patients with multiple sclerosis; a preliminary study [J].
Furlan, R ;
Filippi, M ;
Bergami, A ;
Rocca, MA ;
Martinelli, V ;
Poliani, PL ;
Grimaldi, LME ;
Desina, G ;
Comi, G ;
Martino, G .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1999, 67 (06) :785-788
[5]
Upregulation of the apoptosis regulators cFLIP, CD95 and CD95 ligand in peripheral blood mononuclear cells in relapsing-remitting multiple sclerosis [J].
Gomes, AC ;
Jönsson, G ;
Mjörnheim, S ;
Olsson, T ;
Hillert, J ;
Grandien, A .
JOURNAL OF NEUROIMMUNOLOGY, 2003, 135 (1-2) :126-134
[6]
SOLUBLE ICAM-1 SERUM LEVELS IN MULTIPLE-SCLEROSIS AND VIRAL ENCEPHALITIS [J].
HARTUNG, HP ;
MICHELS, M ;
REINERS, K ;
SEELDRAYERS, P ;
ARCHELOS, JJ ;
TOYKA, KV .
NEUROLOGY, 1993, 43 (11) :2331-2335
[7]
Apoptosis mediators FasL and TRAIL are upregulated in peripheral blood mononuclear cells in MS [J].
Huang, WX ;
Huang, P ;
Gomes, A ;
Hillert, J .
NEUROLOGY, 2000, 55 (07) :928-934
[8]
BREAKDOWN OF THE BLOOD-BRAIN-BARRIER PRECEDES SYMPTOMS AND OTHER MRI SIGNS OF NEW LESIONS IN MULTIPLE-SCLEROSIS - PATHOGENETIC AND CLINICAL IMPLICATIONS [J].
KERMODE, AG ;
THOMPSON, AJ ;
TOFTS, P ;
MACMANUS, DG ;
KENDALL, BE ;
KINGSLEY, DPE ;
MOSELEY, IF ;
RUDGE, P ;
MCDONALD, WI .
BRAIN, 1990, 113 :1477-1489
[9]
Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8. [J].
Kischkel, FC ;
Lawrence, DA ;
Tinel, A ;
LeBlanc, H ;
Virmani, A ;
Schow, P ;
Gazdar, A ;
Blenis, J ;
Arnott, D ;
Ashkenazi, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (49) :46639-46646
[10]
Impaired apoptosis in mitogen-stimulated lymphocytes of patients with multiple sclerosis [J].
Macchi, B ;
Matteucci, C ;
Nocentini, U ;
Caltagirone, C ;
Mastino, A .
NEUROREPORT, 1999, 10 (02) :399-402